SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-063316
Filing Date
2023-03-07
Accepted
2023-03-07 17:30:01
Documents
13
Period of Report
2023-03-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d470831d8k.htm   iXBRL 8-K 49408
2 EX-99.1 d470831dex991.htm EX-99.1 9273
  Complete submission text file 0001193125-23-063316.txt   197552

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA snse-20230307.xsd EX-101.SCH 2843
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE snse-20230307_lab.xml EX-101.LAB 19481
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snse-20230307_pre.xml EX-101.PRE 12148
7 EXTRACTED XBRL INSTANCE DOCUMENT d470831d8k_htm.xml XML 3644
Mailing Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39980 | Film No.: 23714051
SIC: 2834 Pharmaceutical Preparations